期刊文献+

苦参碱通过IL-6/STAT3信号通路抑制人结肠癌细胞 被引量:4

Mechanism of Matrine Inhibiting Human Colon Cancer Cells Through IL-6/STAT3 Signaling Pathway
下载PDF
导出
摘要 目的探讨苦参碱通过IL-6/STAT3信号通路抑制人结肠癌细胞增殖、转移的机制研究。方法通过使用苦参碱干预人结肠癌细胞HCT-116,使用细胞增殖实验CCK-8检测细胞增殖力,使用Western blot实验检测炎性因子IL-6/STAT3基因蛋白表达水平以及结肠癌细胞转移力E-Cad基因蛋白表达水平。结果细胞增殖试验显示,2mg/m L、3mg/m L、4mg/m L苦参碱组较对照组细胞增殖力明显降低。Western blot结果显示,苦参碱组较对照组IL-6/STAT3蛋白表达量明显降低(P<0.05),E-Cad蛋白表达量明显升高(P<0.05)。结论苦参碱可通过抑制IL-6/STAT3信号通路降低人结肠癌细胞HCT-116炎性反应,进一步抑制人结肠癌细胞HCT-116的增殖和转移力,从而达到抗肿瘤作用。 Objective To study the mechanism of matrine inhibiting human colon cancer cells through the IL-6/STAT3 signaling pathway.Method Human colon cancer cell HCT-116 was interfered with matrine,cell proliferation assay CCK-8 was used to detect cell proliferation,and the protein expression level of inflammatory factor IL-6/STAT3 gene and the protein expression level of metastatic power of colon cancer cell E-CAD gene were detected by Western blot assay.Results The cell proliferation test showed that the cell proliferation of 2 mg/mL,3 mg/mL and 4 mg/mL matrine groups was significantly lower than that of the control group.Western blot results showed that the matrine group had IL-6/STAT3 protein compared with the control The expression level was significantly decreased(P<0.05),and the expression level of E-Cad protein was significantly increased(P<0.05).Conclusion Matrine can reduce the inflammatory response of human colon cancer cell HCT-116 by inhibiting IL-6/STAT3 signaling pathway,and further inhibit the proliferation and invasiveness of human colon cancer cell HCT-116,so as to achieve anti-tumor effect.
作者 刘晔 刘斌 LIU Ye;LIU Bin(Department of Laboratory Medicine,Jingbian County People's Hospital,Jingbian Shanxi,718500,China;Department of Laboratory Medicine,Jingbian County Hospital of Traditional Chinese Medicine)
出处 《承德医学院学报》 2021年第2期100-102,共3页 Journal of Chengde Medical University
关键词 HCT-116 IL-6 STAT3 苦参碱 结肠癌 HCT-116 IL-6 STAT3 matrine colon cancer
  • 相关文献

参考文献3

二级参考文献55

  • 1王铁军,李绍平,简家荣,王一涛.苦参碱抗肿瘤作用研究进展[J].中国实验方剂学杂志,2004,10(4):52-55. 被引量:36
  • 2曾晖,邹冰,谭慧珍,梁庆辉,丁飞跃,胡梅洁,章永平,乔敏敏,吴云林.苦参碱联合5-FU抑制人胃癌裸鼠移植瘤的生长作用及机制[J].广州中医药大学学报,2006,23(2):164-167. 被引量:22
  • 3Zhang LP, Jiang JK, Tam TW, et al. Effects of matrine on proliferation differentiation in K562 cells[J]. Leuk Res, 2001, 25 (9): 793-800. 被引量:1
  • 4Hua J, Chun HH, Shu BZ, et al. Matrine upregulates the cell cycle protein E2F-1 and triggers apoptosis via the mitochondrial pathway in K562 cells [J]. Eur J Pharmacol, 2007, 559: 98-108. 被引量:1
  • 5Hohenberger W, Weber K, Matzel K, et al. Standardized surgery for colonic cancer: complete mesocolic excision and central ligation--technical notes and outcome ~J]. ColorectalDis, 2009,11 ( 4 ) : 354-365. DOI: 10.1111/j.1463-1318.2008. 01735.x. 被引量:1
  • 6West NP, Hohenberger W, Weber K, et al. Complete mesoeolie excision with central vascular ligation produces an oneologieally superior specimen compared with standard surgery for carcinoma of the colon[J]. J Clin Oneol, 2010,28(2) :272- 278. DOI: 10.1200/JCO.2009.24.1448. 被引量:1
  • 7P~hlman L, Bohe M, Cedermark B, et al. The Swedish rectal cancer registry[J]. Br J Surg, 2007,94(10) : 1285-1292. 被引量:1
  • 8Andr~ T, Boni C, Navarro M, et al. Improved overall survival with oxaliplatin, fluorouracil, and leueovorin as adjuvant treatment in stage II or I!I colon cancer in the MOSAIC trial. J Clin Oneol, 2009,27(19) :3109-3116. DOI: 10.1200/JCO.2008. 20.6771. 被引量:1
  • 9Twelves C, Wang A, Nowaeki MP, et al. Capeeitabine as adjuvant treatment for stagem colon cancer[J]. N Engl J Med, 2005,352(26) :2696-2704. DOI: 10.1056/NEJMoa043116. 被引量:1
  • 10Biagi JJ, Raphael M J, Mackillop WJ, et al. Association between time to initiation of adjuvant chemotherapy and survival in calorectal cancer: a systematic review and meta-analysis [J]. JAMA, 2011,305 (22) :2335-2342. DOI: 10.1001/jama.2011.749. 被引量:1

共引文献56

同被引文献32

引证文献4

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部